Pay in 4 interest-free payments of $7.16 Learn more
Ships within 48 hours · Estimated delivery Aug 26 - Aug 31
Published pre-clinical studies have used FOXO4-DRI to demonstrate that selective elimination of senescent cells in aged mouse models can improve a range of tissue function parameters including fitness, fur density, renal function, and liver function establishing the broader research principle that senescent cell burden contributes meaningfully to ageing tissue dysfunction and that its targeted reduction produces measurable functional benefits in experimental models
Dosing: Weekly injections, same cadence as current GLP-1 therapies no daily administration required
What counts is a healthy lifestyle
Most clinical evidence is topical
US$ 21.05
US$ 26.29
US$ 28.24
US$ 24.37
US$ 25.41
US$ 25.75
